血浆可溶性细胞间黏附分子-1在生物标志物网络分析中居核心地位,并与两个不同的儿童急性呼吸窘迫综合征和急性呼吸衰竭队列的不良结局相关
本研究为前瞻性队列研究的二次分析,纳入两个多中心儿科重症监护病房队列:急性呼吸窘迫综合征患儿214例(PALI,2008-2014)和急性呼吸衰竭患儿251例(CAF-PINT,2012-2016)。在诊断后72小时内采集血浆测定可溶性细胞间黏附分子-1水平,主要结局为住院死亡率(分别为18%和14%)。在两个队列中,较高的血浆可溶性细胞间黏附分子-1均与住院死亡、多器官功能障碍和较少的无呼吸机天数相关(均P<0.05)。生物标志物网络分析显示,可溶性细胞间黏附分子-1(中心性0.74)与组织金属蛋白酶抑制物-1(0.99)、肿瘤坏死因子受体-1(0.83)和白细胞介素-8(0.74)同为网络枢纽。
要点
- 在儿童急性呼吸窘迫综合征队列(PALI,n=214)中,较高的血浆可溶性细胞间黏附分子-1水平与住院死亡、多器官功能障碍和较少的无呼吸机天数相关(均P<0.05)。
- 在儿童急性呼吸衰竭队列(CAF-PINT,n=251)中,较高的血浆可溶性细胞间黏附分子-1水平同样与住院死亡、多器官功能障碍和较少的无呼吸机天数相关(均P<0.05)。
- 两个队列住院死亡率分别为18%(PALI)和14%(CAF-PINT),基线中位氧合指数比分别为10(IQR 5.6-19.7)和8.5(IQR 3.5-17.7)。
- 网络分析中,组织金属蛋白酶抑制物-1(复合中心性0.99)、肿瘤坏死因子受体-1(0.83)、可溶性细胞间黏附分子-1(0.74)和白细胞介素-8(0.74)被识别为网络枢纽。
- 可溶性细胞间黏附分子-1被识别为网络中心枢纽,其特征为高中心性度量,提示其在白细胞跨内皮迁移、炎症和内皮功能障碍中可能起多方面作用。
适用人群与场景
- 儿童急性呼吸窘迫综合征患者:来自PALI队列(2008-2014),年龄为危重儿童,纳入多中心儿科重症监护病房。
- 儿童急性呼吸衰竭患者:来自CAF-PINT队列(2012-2016),年龄为危重儿童,纳入多中心儿科重症监护病房。
研究设计与关键结果
- 研究设计:前瞻性队列研究的二次分析,多中心儿科重症监护病房,无干预。
- 样本量:PALI队列214例儿童急性呼吸窘迫综合征患者,CAF-PINT队列251例儿童急性呼吸衰竭患者。
- 主要终点:住院死亡率,PALI队列为18%,CAF-PINT队列为14%。
- 次要终点:多器官功能障碍和無呼吸机天数;在两个队列中,较高的血浆可溶性细胞间黏附分子-1水平均与住院死亡、多器官功能障碍和较少的无呼吸机天数相关(均P<0.05)。
- 基线中位氧合指数比:PALI队列为10(IQR 5.6-19.7),CAF-PINT队列为8.5(IQR 3.5-17.7)。
- 网络分析:可溶性细胞间黏附分子-1与32种反映炎症、内皮和上皮损伤及细胞外基质降解的血浆生物标志物构建相关性网络;中心性度量位于前10%(≥90百分位)的生物标志物定义为关键枢纽。
- 网络枢纽:组织金属蛋白酶抑制物-1(复合中心性0.99)、肿瘤坏死因子受体-1(0.83)、可溶性细胞间黏附分子-1(0.74)和白细胞介素-8(0.74)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些发现强调可溶性细胞间黏附分子-1在白细胞跨内皮迁移、炎症和内皮功能障碍中的多方面作用,并突出其在急性呼吸窘迫综合征病理生理学中的关键作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Intercellular adhesion molecule-1 (ICAM-1) is a glycoprotein expressed on immune, endothelial, and epithelial cells. In the setting of inflammation, it becomes upregulated and spliced into a soluble form (soluble ICAM-1 [sICAM-1]). This study examined the association of sICAM-1 with clinical outcomes in two large pediatric cohorts with acute respiratory distress syndrome (ARDS) and acute respiratory failure (ARF) and examined the relationships between sICAM-1 and other protein biomarkers utilizing network analysis to contextualize its role in ARDS pathophysiology.
DESIGN: Secondary analysis of prospective cohort studies.
SETTING: Multicenter PICUs.
PATIENTS OR SUBJECTS: Critically ill children with ARDS (Pediatric Acute Lung Injury [PALI], 2008-2014) and ARF (Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial [CAF-PINT], 2012-2016).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: sICAM-1 levels were measured from plasma collected within 72 hours of diagnosis. The primary outcome was in-hospital mortality, and secondary outcomes included multiple organ dysfunction and ventilator-free days. We constructed a biomarker correlation-based network that included sICAM-1 and 32 plasma biomarkers reflective of inflammation, endothelial and epithelial injury, and extracellular matrix degradation. Key biomarkers with centrality metrics in the top 10% (≥ 90th percentile) were defined as critical hubs within the network. The study included 214 children from PALI and 251 from CAF-PINT. In-hospital mortality was 18% and 14%, respectively. Baseline median oxygenation index ratios were 10 (interquartile range [IQR], 5.6-19.7) and 8.5 (IQR, 3.5-17.7). Higher plasma sICAM-1 was associated with in-hospital mortality, multiple organ dysfunction, and fewer ventilator-free days in each of the two cohorts (all p < 0.05). Tissue inhibitor of metalloproteinase-1 (composite centrality, 0.99), tumor necrosis factor receptor-1 (0.83), sICAM-1 (0.74), and interleukin-8 (0.74) were identified as network hubs.
CONCLUSIONS: Elevated sICAM-1 levels were associated with poor outcomes in two separate cohorts of ARDS and ARF patients. Network analysis revealed sICAM-1 as a central hub, characterized by high centrality metrics. These findings underscore the multifaceted role of sICAM-1 in leukocyte transmigration, inflammation, and endothelial dysfunction and highlight its critical role in ARDS pathophysiology.
参考来源
- Lim MJ, Whitney JE, Sallee CJ, et al. Plasma Soluble Intercellular Adhesion Molecule-1 Has a Central Role in Biomarker Network Analysis and Is Associated With Poor Outcomes in Two Distinct Pediatric Cohorts of Acute Respiratory Distress Syndrome and Acute Respiratory Failure. Crit Care Med. 2025. PMID: 40459371. doi:10.1097/CCM.0000000000006719
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。